Cornell University, Weill Medical College, Ithaca
Vaginally delivered SIV-cell fusion inhibitors protect macaques from SHIV infection
Published in Law and Health Weekly, December 31st, 2005
According to a study from the United States, "Human immunodeficiency virus type 1 (HIV-1) continues to spread, principally by heterosexual sex, but no vaccine is available. Hence, alternative prevention methods are needed to supplement educational and behavioral-modification programs. One such approach is a vaginal microbicide: the application of inhibitory compounds before intercourse."
"We have evaluated the microbicide concept using the rhesus macaque 'high dose' vaginal transmission model with a CCR5-receptor-using simian-human immunodeficiency virus...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Law and Health Weekly
More Articles from Law and Health Weekly
- Aptuit, Inc.
Drug development support company names Paul Lubetkin as general counsel - Axis-Shield plc
New program to develop biosensors for diagnosis of infectious diseases - BioElectronics Corp.
New ActiPatch is thinner, more comfortable - British Natl Inst for Biol Standards & Control
Research add new data to HIV/AIDS vaccines development body of knowledge - Cigna HealthCare
Cigna expands comarketing for Cignature Rx prescription drug plan - GlaxoSmithKline Biologicals
Institut Pasteur, drug maker to develop AIDS vaccine - More from this issue of Law and Health Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
